Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Clonal replacement of tumor-specific T cells following PD-1 blockade
Kathryn E. Yost, Ansuman T. Satpathy, Daniel K. Wells, et al.
Nature Medicine (2019) Vol. 25, Iss. 8, pp. 1251-1259
Open Access | Times Cited: 1135

Showing 1-25 of 1135 citing articles:

Nivolumab plus Ipilimumab in Advanced Non–Small-Cell Lung Cancer
Matthew D. Hellmann, Luís Paz-Ares, Reyes Bernabé, et al.
New England Journal of Medicine (2019) Vol. 381, Iss. 21, pp. 2020-2031
Open Access | Times Cited: 2305
The history and advances in cancer immunotherapy: understanding the characteristics of tumor-infiltrating immune cells and their therapeutic implications
Yuanyuan Zhang, Zemin Zhang
Cellular and Molecular Immunology (2020) Vol. 17, Iss. 8, pp. 807-821
Open Access | Times Cited: 1850
Immune Checkpoint Inhibitors for the Treatment of Cancer: Clinical Impact and Mechanisms of Response and Resistance
Sreya Bagchi, Robert Yuan, Edgar G. Engleman
Annual Review of Pathology Mechanisms of Disease (2020) Vol. 16, Iss. 1, pp. 223-249
Open Access | Times Cited: 1476
Tumour-intrinsic resistance to immune checkpoint blockade
Anusha Kalbasi, Antoni Ribas
Nature reviews. Immunology (2019) Vol. 20, Iss. 1, pp. 25-39
Open Access | Times Cited: 1122
Tumor microenvironment as a therapeutic target in cancer
Yi Xiao, Dihua Yu
Pharmacology & Therapeutics (2020) Vol. 221, pp. 107753-107753
Open Access | Times Cited: 1089
CD8+ T cell states in human cancer: insights from single-cell analysis
Anne M. van der Leun, Daniela S. Thommen, Ton N. Schumacher
Nature reviews. Cancer (2020) Vol. 20, Iss. 4, pp. 218-232
Open Access | Times Cited: 1072
Immune cells within the tumor microenvironment: Biological functions and roles in cancer immunotherapy
Lei Xu, Yu Lei, Jin-ke Li, et al.
Cancer Letters (2019) Vol. 470, pp. 126-133
Closed Access | Times Cited: 1069
Systemic immunity in cancer
Kamir J. Hiam-Galvez, Breanna M. Allen, Matthew H. Spitzer
Nature reviews. Cancer (2021) Vol. 21, Iss. 6, pp. 345-359
Open Access | Times Cited: 922
Massively parallel single-cell chromatin landscapes of human immune cell development and intratumoral T cell exhaustion
Ansuman T. Satpathy, Jeffrey M. Granja, Kathryn E. Yost, et al.
Nature Biotechnology (2019) Vol. 37, Iss. 8, pp. 925-936
Open Access | Times Cited: 774
Multimodal Analysis of Composition and Spatial Architecture in Human Squamous Cell Carcinoma
Andrew L. Ji, Adam J. Rubin, Kim Thrane, et al.
Cell (2020) Vol. 182, Iss. 2, pp. 497-514.e22
Open Access | Times Cited: 748
TISCH: a comprehensive web resource enabling interactive single-cell transcriptome visualization of tumor microenvironment
Dongqing Sun, Jin Wang, Ya Han, et al.
Nucleic Acids Research (2020) Vol. 49, Iss. D1, pp. D1420-D1430
Open Access | Times Cited: 746
Neoadjuvant checkpoint blockade for cancer immunotherapy
Suzanne L. Topalian, Janis M. Taube, Drew M. Pardoll
Science (2020) Vol. 367, Iss. 6477
Open Access | Times Cited: 745
Developmental Relationships of Four Exhausted CD8+ T Cell Subsets Reveals Underlying Transcriptional and Epigenetic Landscape Control Mechanisms
Jean‐Christophe Beltra, Sasikanth Manne, Mohamed S. Abdel-Hakeem, et al.
Immunity (2020) Vol. 52, Iss. 5, pp. 825-841.e8
Open Access | Times Cited: 683
Neoadjuvant chemotherapy and nivolumab in resectable non-small-cell lung cancer (NADIM): an open-label, multicentre, single-arm, phase 2 trial
Mariano Provencio, Ernest Nadal, Amelia Insa, et al.
The Lancet Oncology (2020) Vol. 21, Iss. 11, pp. 1413-1422
Closed Access | Times Cited: 642
CD8+ T cell differentiation and dysfunction in cancer
Mary Philip, Andrea Schietinger
Nature reviews. Immunology (2021) Vol. 22, Iss. 4, pp. 209-223
Open Access | Times Cited: 615
Acquired Resistance to Immune Checkpoint Inhibitors
Adam J. Schoenfeld, Matthew D. Hellmann
Cancer Cell (2020) Vol. 37, Iss. 4, pp. 443-455
Open Access | Times Cited: 609
Tumor-infiltrating lymphocytes in the immunotherapy era
Sterre T. Paijens, Annegé Vledder, Marco de Bruyn, et al.
Cellular and Molecular Immunology (2020) Vol. 18, Iss. 4, pp. 842-859
Open Access | Times Cited: 601
Peripheral T cell expansion predicts tumour infiltration and clinical response
Thomas D. Wu, Shravan Madireddi, Patrícia E. de Almeida, et al.
Nature (2020) Vol. 579, Iss. 7798, pp. 274-278
Closed Access | Times Cited: 578
Intratumoral heterogeneity in cancer progression and response to immunotherapy
Ilio Vitale, Efrat Shema, Sherene Loi, et al.
Nature Medicine (2021) Vol. 27, Iss. 2, pp. 212-224
Closed Access | Times Cited: 545
A single-cell map of intratumoral changes during anti-PD1 treatment of patients with breast cancer
Ayse Bassez, Hanne Vos, Laurien Van Dyck, et al.
Nature Medicine (2021) Vol. 27, Iss. 5, pp. 820-832
Open Access | Times Cited: 509
Macrophage-Derived CXCL9 and CXCL10 Are Required for Antitumor Immune Responses Following Immune Checkpoint Blockade
Imran G. House, Peter Savas, Junyun Lai, et al.
Clinical Cancer Research (2019) Vol. 26, Iss. 2, pp. 487-504
Open Access | Times Cited: 481
SPOTlight: seeded NMF regression to deconvolute spatial transcriptomics spots with single-cell transcriptomes
Marc Elosua-Bayés, Paula Nieto, Elisabetta Mereu, et al.
Nucleic Acids Research (2021) Vol. 49, Iss. 9, pp. e50-e50
Open Access | Times Cited: 474
Single-cell analyses reveal key immune cell subsets associated with response to PD-L1 blockade in triple-negative breast cancer
Yuanyuan Zhang, Hongyan Chen, Hongnan Mo, et al.
Cancer Cell (2021) Vol. 39, Iss. 12, pp. 1578-1593.e8
Open Access | Times Cited: 453
The Tumor Microenvironment in the Response to Immune Checkpoint Blockade Therapies
Florent Petitprez, Maxime Meylan, Aurélien de Reyniès, et al.
Frontiers in Immunology (2020) Vol. 11
Open Access | Times Cited: 451
The PD-1/PD-L1-Checkpoint Restrains T cell Immunity in Tumor-Draining Lymph Nodes
Floris Dammeijer, Mandy van Gulijk, Evalyn E.A.P. Mulder, et al.
Cancer Cell (2020) Vol. 38, Iss. 5, pp. 685-700.e8
Open Access | Times Cited: 447
Page 1 - Next Page

Scroll to top